Literature DB >> 29210640

Fine-tuning of microRNAs in Type 2 Diabetes Mellitus.

Juan A Rosado1, Raquel Diez-Bello1, Ginés M Salido1, Isaac Jardin1.   

Abstract

Type 2 diabetes mellitus is a metabolic disease widely spread across industrialized countries. Sedentary lifestyle and unhealthy alimentary habits lead to obesity, boosting both glucose and fatty acid in the bloodstream and eventually, insulin resistance, pancreas inflammation and faulty insulin production or secretion, all of them very well-defined hallmarks of type 2 diabetes mellitus. miRNAs are small sequences of non-coding RNA that may regulate several processes within the cells, fine-tuning protein expression, with an unexpected and subtle precision and in time-frames ranging from minutes to days. Since the discovery of miRNA and their possible implication in pathologies, several groups aimed to find a relationship between type 2 diabetes mellitus and miRNAs. Here we discuss the pattern of expression of different miRNAs in cultured cells, animal models and diabetic patients. We summarize the role of the most important miRNAs involved in pancreas growth and development, insulin secretion and liver, skeletal muscle or adipocyte insulin resistance in the context of type 2 diabetes mellitus. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  biomarkers; gene-directed therapies; insulin resistance; insulin secretion; miRNAs; pancreas development; type 2 diabetes mellitus.

Mesh:

Substances:

Year:  2019        PMID: 29210640     DOI: 10.2174/0929867325666171205163944

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  4 in total

1.  Transgenic overexpression of microRNA-30d in pancreatic beta-cells progressively regulates beta-cell function and identity.

Authors:  Yiping Mao; Jacob Schoenborn; Zhihong Wang; Xinqian Chen; Katy Matson; Ramkumar Mohan; Shungang Zhang; Xiaohu Tang; Anoop Arunagiri; Peter Arvan; Xiaoqing Tang
Journal:  Sci Rep       Date:  2022-07-13       Impact factor: 4.996

Review 2.  Therapeutic Potential of miRNAs for Type 2 Diabetes Mellitus: An Overview.

Authors:  Pads Palihaderu; Bilm Mendis; Jmkjk Premarathne; Wkrr Dias; Swee Keong Yeap; Wan Yong Ho; A S Dissanayake; I H Rajapakse; P Karunanayake; U Senarath; D A Satharasinghe
Journal:  Epigenet Insights       Date:  2022-10-15

3.  The Role of H2S in the Metabolism of Glucose and Lipids.

Authors:  Hai-Jian Sun; Zhi-Yuan Wu; Xiao-Wei Nie; Jin-Song Bian
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  MiR-142-3p ameliorates high glucose-induced renal tubular epithelial cell injury by targeting BOD1.

Authors:  Ningmin Zhao; Qing Luo; Ruijuan Lin; Qiaoyan Li; Peizhi Ma
Journal:  Clin Exp Nephrol       Date:  2021-06-18       Impact factor: 2.617

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.